SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950123-11-021508
Filing Date
2011-03-03
Accepted
2011-03-03 09:32:15
Documents
9
Period of Report
2010-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K b84113e10vk.htm 10-K 1492054
2 EX-10.45 b84113exv10w45.htm EX-10.45 75274
3 EX-21.1 b84113exv21w1.htm EX-21.1 2392
4 EX-23.1 b84113exv23w1.htm EX-23.1 1644
5 EX-31.1 b84113exv31w1.htm EX-31.1 8129
6 EX-31.2 b84113exv31w2.htm EX-31.2 8157
7 EX-32.1 b84113exv32w1.htm EX-32.1 4247
8 EX-32.2 b84113exv32w2.htm EX-32.2 4279
9 GRAPHIC b84113b8411301.gif GRAPHIC 6774
  Complete submission text file 0000950123-11-021508.txt   1607200
Mailing Address 1255 CRESCENT GREEN DRIVE SUITE 250 CARY NC 27518
Business Address 1255 CRESCENT GREEN DRIVE SUITE 250 CARY NC 27518 919-678-6611
CORNERSTONE THERAPEUTICS INC (Filer) CIK: 0001145404 (see all company filings)

IRS No.: 043523569 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-50767 | Film No.: 11658581
SIC: 2834 Pharmaceutical Preparations